Why U.S. Regulators Are Cracking Down on Private Equity Investments in the Healthcare Sector
August 11, 2025
Global Competition Review – Americas Antitrust Review 2026
Axinn managing partner Jeny Maier, counsel Monica Smith, and associate Leandra Ipiña co-authored a chapter in Global Competition Review’s Americas Antitrust Review 2026 titled “Why U.S. Regulators Are Cracking Down on Private Equity Investments in the Healthcare Sector.”
Click here to access the chapter.
Accreditation: This article was first published on Global Competition Review in August 2025; for further in-depth analysis, please visit GCR - Americas Antitrust Review 2026
To subscribe to our publications, click here.
Featured Insights
Featured Insights
IBA Annual Conference 2025
Speaking Engagement
Antitrust
GCR Live: Global Merger Control 2025
Speaking Engagement
Antitrust
Thomson Reuters 24th Annual Law Firm COO & CFO Forum
Speaking Engagement
LegalNEXT 2025
Speaking Engagement
Antitrust
Informa Antitrust Texas 2025
Speaking Engagement
Antitrust
Shifting Trends in Healthcare Antitrust Enforcement: Navigating the Evolving Landscape
Axinn Viewpoints
Antitrust
ACI Forum on Pharma & Biotech Patent Litigation USA 2025
Speaking Engagement
Intellectual Property
MCCA Gala 2025
Sponsorship
Antitrust
In Fashion, One Day You’re In and the Next Day You’re Out (Of Chances to Plead Violations of the Sherman Act)
Axinn Viewpoints
Antitrust
Axinn Honored at the 2025 Transform Awards North America
Awards & Recognitions